{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:29:36Z","timestamp":1775604576052,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Association of immunotherapy and\/or chemotherapy and\/or targeted therapy, in sequence or as single therapies, may induce osteonecrosis of the jaw. Multidisciplinary team management of these patients should be provided.<\/jats:p>","DOI":"10.1002\/ccr3.3418","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:28:25Z","timestamp":1606948105000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["New\u2010generation anticancer drugs and medication\u2010related osteonecrosis of the jaw (MRONJ): Late onset 3\u00a0years after ipilimumab endovenous administration with a possible role of target therapy"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-1301","authenticated-orcid":false,"given":"Agostino","family":"Guida","sequence":"first","affiliation":[{"name":"Maxillo\u2010facial and ENT Surgery Unit INT \u2013 IRCCS \u201cFondazione G. Pascale\u201d Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8158-7509","authenticated-orcid":false,"given":"Francesco","family":"Perri","sequence":"additional","affiliation":[{"name":"Head &amp; Neck\/Thyroid Medical Oncology Unit INT \u2013 IRCCS \u201cFondazione G. Pascale\u201d Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Ionna","sequence":"additional","affiliation":[{"name":"Maxillo\u2010facial and ENT Surgery Unit INT \u2013 IRCCS \u201cFondazione G. Pascale\u201d Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo A.","family":"Ascierto","sequence":"additional","affiliation":[{"name":"Melanoma, Oncological Immunotherapy and Innovative Therapies Department INT \u2013 IRCCS \u201cFondazione G. Pascale\u201d Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio M.","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"Melanoma, Oncological Immunotherapy and Innovative Therapies Department INT \u2013 IRCCS \u201cFondazione G. Pascale\u201d Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"e_1_2_11_3_1","first-page":"2","volume-title":"DearDoctor. Precautions Added to the Label of Aredia and Zometa","author":"Hohnecker JA","year":"2004"},{"key":"e_1_2_11_4_1","unstructured":"United States Food and Drug Administration Office of Drug Safety: Postmarketing safety review.Bisphosphonates.http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/20054095B2_03_04\u2010FDA\u2010Tab3.pdf. Accessed October 09 2019."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.8604"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7101"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2012.08.439"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2015.12.005"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2011.06.023"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.5424"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2011.08.024"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2013.09.008"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2015.08.014"},{"issue":"2","key":"e_1_2_11_14_1","article-title":"Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district","volume":"102","author":"Ponzetti A","year":"2016","journal-title":"Tumori"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2016.05.07"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2016.06"},{"key":"e_1_2_11_17_1","first-page":"29","article-title":"Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib: a case report with clinical implications","volume":"4","author":"Nicolatou\u2010Galitis O","year":"2013","journal-title":"Forum Clin Oncol"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.02.003"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104659"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2020.01.014"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/249073"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.20589"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12764"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1823"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/46303"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30501-0"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21940"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0118"}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.3418","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.3418","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.3418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:06:27Z","timestamp":1692813987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.3418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1002\/ccr3.3418"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.3418","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"2020-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}